Platinum-resistant Ovarian Cancer Recruiting Phase 1 Trials for PHI-101 (DB17237)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04678102Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)Treatment